For people with relapsing multiple sclerosis, a changing landscape of treatment options can mean new information to consider, new questions for your neurologist, and possibly even new treatment decisions. Whether your current treatment plan is effectively treating your MS or you’re thinking about switching disease-modifying treatments (DMTs), it’s good to know about your options.
When talking to your physician, it’s not all about what to ask; it can be just as important to know what to tell them. Your neurologist is your partner in treating relapsing MS. It’s vital to let them know about new symptoms, your personal treatment preferences, and any challenges you have with taking medication as prescribed.
This guide is designed to help you communicate your treatment goals and preferences with your doctor, so you can decide on your best treatment option. When you’re ready to discuss treatments with your doctor, bring this article to help facilitate the conversation.
Help your health care provider understand whether your condition is changing and your preferences for medication. When you meet with your doctor, tell them if you are experiencing new symptoms or worsening symptoms.
Consider the following aspects of MS treatment and make a note of what feels important to you, so you can let your doctor know.
Which of these statements feels more true to you?
Which of these statements feels more true to you?
Which of these statements feels more true to you?
Be clear with your doctor about any challenges you experience in sticking to your current treatment plan. Do you experience any of the following issues?
These 14 questions can help you discover the information you need to make the best choices for your MS treatment. Look them over and make a note of any you’d like to bring up with your doctor at your next appointment.
5. Do you think I might benefit from switching to a different DMT? Why or why not?
6. If you recommend against switching now, can we set a time in the future to discuss it again?
7. Why do you think a new DMT may be more effective for me than my current treatment?
8. What are the potential benefits and risks of switching to this treatment?
9. Will I need a washout period to get my current treatment out of my system before beginning the new DMT? Is my risk for an MS flare higher during the washout period?
10. What is my personal risk for developing rare but serious side effects with this treatment?
11. How (and how often) will my risk for serious side effects be monitored while I’m taking this treatment?
12. What are the most common side effects of this treatment? How long are they likely to last? Is there anything I can do to avoid or manage them?
13. How long will it be before my new treatment begins taking effect?
14. Which treatments are covered by my health care plan?
MS is an autoimmune condition in which the immune system attacks the myelin coating on the nerve cells of the central nervous system (brain and spinal cord). The progression of the disease depends on the type of MS. Periodic flare-ups are the hallmark of the relapsing forms of MS:
It’s important to remember that MS can progress even without exacerbations, new lesions, or new symptoms of MS. This is why it’s so important to form a partnership with your neurologist, get MRI scans and blood tests as needed, and communicate openly about your symptoms and quality of life.
Read more about how treatments for relapsing MS work. Do you know which treatments are considered highly effective?
On MyMSTeam, the social network for people with multiple sclerosis and their loved ones, more than 195,000 members come together to ask questions, give advice, and share their stories with those who understand life with MS.
Have you asked these questions in a conversation with your doctor? What do you recommend others with MS ask their doctors? Share in the comments below, or start a conversation with others on MyMSTeam.
Don’t miss the latest news, tips and treatment options.
Privacy policy
Become a Subscriber
Get the latest articles about multiple sclerosis sent to your inbox.